Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 344 results for "erbitux"

BRIEF-Merck sees continued price pressure for Erbitux in the EU

n"Nov 15 Merck * CEO says price pressure and competition for Erbitux in the EU will continue Further Reuters UK, 2 weeks ago

5 images for erbitux

pharmaphorum, 1 month ago
Pharmafile, 5 months ago
Nasdaq, 5 months ago
European Pharmaceutical Manufacturer, 5 months ago
Nasdaq, 7 months ago
pharmaphorum

Erbitux woes aside, cost-cutting lifts Q3 earnings and forecast from Merck KGaA

Two weeks ago, Germany's Merck KGaA suffered a blow in the U.K., when the country's cost-effectiveness watchdog NICE ruled that the benefits of its drug Erbitux in head and neck cancer do not justify its price. Now the company is acknowledging that ...
 FiercePharma2 weeks ago NICE says head and neck cancer drug cetuximab is not cost-effective  European Pharmaceutical Review4 weeks ago NICE says Merck KGaA's Erbitux falls short in mouth cancer, despite new discount, data  FiercePharma1 month ago NICE says Merck head and neck cancer drug Erbitux is not cost-effective  Pharma Letter1 month ago

Global Erbitux Market Opportunities and Development Forecast 2016-2021

(Before It's News) The Global Erbitux market sales report addresses the detail source of information which offers a telescopic view of the current and future market status. Various key factors are discussed in the report, which will help the ...
 Before It's News3 weeks ago Erbitux Drug Market 2016 Overview, Trend and Analysis  MyNewsDesk1 month ago Global Erbitux Market by Type ,by Regions & by Application and by Manufacturers  MyNewsDesk1 month ago

New and Generic Drug Approvals: Erbitux

Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to
 U.S. Food and Drug Administration1 month ago
Zacks.com

Amgen/Allergan File for EU Approval of Avastin Biosimilar

Amgen Inc. AMGN, along with partner Allergan plc. AGN, announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ABP 215, their biosimilar version of Roche Holding AG's RHHBY cancer drug ...
 Yahoo! Singapore2 hours ago
[x]  
American Banking News

Analysts Downgrades for December, 5th (ANET, BERY, BRO, BSRR, CAB, CDE, CLF, CLR, CLVS, CNSL)

Arista Networks (NYSE:ANET) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating. Berry Plastics Group (NYSE:BERY) was downgraded by analysts at Macquarie from an outperform rating to a neutral rating. ...
 American Banking News3 hours ago Analysts Downgrades for October, 5th (BMO, CRZBY, CVX, EBS, FLR, IMGN, KSU, LLY, RST, RUSHA)  SleekMoney2 months ago

4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential

One thing that many on Wall Street felt was hampering the pharmaceutical and medical technology stocks was the potential for a Hillary Clinton victory last month. Her harsh rhetoric on drug pricing cast a pall over both areas and they each have ...
 24/7 Wall St3 hours ago

The future of molecular diagnostics for cancer.

The pharmaceutical industry is still struggling to cure cancer despite pouring enormous resources into the search for new treatments. We take a look at the some of the current technologies for the discovery and delivery of molecular diagnostic, ...
 Drug Discovery World7 hours ago
24/7 Wall St

5 Dividend Retirement Stocks to Buy Now and Hold Forever

Source: ThinkstockWhile interest rates have jumped dramatically recently, much of it has to do with market anticipation on what most experts feel will be a December rate hike by the Federal Reserve of one-quarter of a percentage point, or 25 basis ...
 24/7 Wall St3 days ago 4 Merrill Lynch US 1 Stocks to Buy That Also Pay Solid Dividends  24/7 Wall St1 month ago

Trump's election threatens medical cooperation between US and Cuba

HAVANA — Cuba's government-run biotech industry is one of the lesser-known legacies of Fidel Castro: It employs 22,000 scientists, engineers, and technicians on modern campuses here, sells drugs in 23 countries, and wants to bring its products to ...
 StatNews.com3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less